Nemesis Bioscience Ltd announced today that it has been awarded a European Innovation Council (EIC) Accelerator grant of €2 million to advance its work in the prevention of antibiotic -resistant infections. In this highly competitive process, Nemesis was one of only 74 companies funded from many thousands of applicants. In a two-year, EIC funded programme, Nemesis

Nemesis Bioscience Ltd announced today that it had appointed Dr Yoshinori Yamano to its board as a non-executive director. Dr Yamano is currently Chief Scientific Officer

Nemesis Bioscience Ltd announced today that it had reached an agreement on terms for a two-year research collaboration with Shionogi & Co. Ltd. to further

Nemesis Bioscience has been successful in winning a £414, 000 award granted by the UK’s innovation agency, Innovate UK. The Small Business Research Initiative (SBRI)

Nemesis Bioscience today announced the expansion of its presence in Aberystwyth by opening a new pre-clinical development facility at the University. Having become members at

New Chairman Brings “Wealth of Experience” to Pioneering Biotech Firm Simon Sturge, Executive Vice President of Business, Operations and Strategy at Merck Healthcare, is today confirmed as

PHOTO:  From Left: Prof Conrad Lichtenstein (Nemesis CSO), Dr Frank Massam (Nemesis CEO), Dr Takeshi Shiota (Shionogi SVP, Pharmaceutical Research Division) and Dr Kai Stoeber

Nemesis Bioscience today announced the appointment of Dr Mark McCamish as Scientific Advisor for the development of its suite of Bacterial Cybergenetics© technologies. These include

Nemesis Bioscience today announced the successful completion of its latest funding round, bringing total seed funds raised to more than £700,000, and the commencement of

Nemesis Bioscience today announced the appointment of Dr Alastair Riddell as non-executive Chairman. The appointment is effective from the 1st July and will bring Alastair’s considerable experience into the company as it continues to rapidly grow the business around its portfolio of Nemesis Symbiotics© which inactivate antibiotic resistance in pathogenic bacteria Alastair has over 30 years